Rockwell Medical Files Form 8-K on Mar 26, 2026 Rockwell Medical (RMTI) filed a Form 8-K on Mar 26, 2026 (10:20:37 GMT); examine timing, 4-business-day SEC rule and sector implications.

Rockwell Medical Files Form 8-K on Mar 26, 2026: Rockwell Medical (RMTI) filed a Form 8-K on Mar 26, 2026 (10:20:37 GMT); examine timing, 4-business-day SEC rule and sector implications. 👈 Read full analysis #RockwellMedical #RMTI #Form8K #SECfiling #MarketAnalysis

Rockwell Medical Announces Fourth Quarter and Full-Year 2025 Financial and Operational Results Rockwell Medical, Inc., a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced financial and operational results for the three and twelve months ended December 31, 2025.. "2025 was a year of transition for Rockwell Medical.

#RMTI Rockwell Medical Announces Fourth Quarter and Full-Year 2025 Financial and Operational Results

www.stocktitan.net/news/RMTI/rockwell-medic...

Rockwell Medical to Release Fourth Quarter and Full-Year 2025 Results on Thursday, March 26, 2026 Rockwell Medical (Nasdaq: RMTI) will release fourth-quarter and full-year 2025 results on Thursday, March 26, 2026. A press release will be issued at 6:00 AM ET followed by a live webcast at 8:00 AM ET.Management speakers include Mark Strobeck, Ph.D., president and CEO, and Jesse Neri, SVP and CFO. The webcast will include discussion of financial and operational results followed by a Q&A. Replay will be available at www.RockwellMed.com/Results.

#RMTI Rockwell Medical to Release Fourth Quarter and Full-Year 2025 Results on Thursday, March 26, 2026

www.stocktitan.net/news/RMTI/rockwell-medic...

Rockwell Medical Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Financial Results Rockwell Medical (Nasdaq: RMTI) reported preliminary unaudited results for Q4 and full-year 2025. The company expects Q4 net sales of ~$18.6M and FY 2025 net sales of ~$69.5M. Q4 gross margin is expected to be ~22%, up from 14% in Q3 2025. Management says the company was cash flow positive in Q4 with operating cash flow of ~$2.3M (the second positive quarter in 2025), and expects cash and investments to increase to ~$25M at December 31, 2025. Results are preliminary, unaudited, and subject to year-end close adjustments.

#RMTI Rockwell Medical Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Financial Results

www.stocktitan.net/news/RMTI/rockwell-medic...

Rockwell Medical Adds 30 New Customers in the West Rockwell Medical (Nasdaq: RMTI) added 30 new customers in the western United States and reports the Western U.S. now accounts for more than 10% of its customer clinic footprint. The company said this expansion generated multi-million dollars in revenue from the new west coast customer base. Rockwell attributes the growth to rapid scaling of production and expanded logistics after meaningful supply-chain disruption for hemodialysis concentrates in the region. New customers include a large integrated non-profit healthcare system, a California chronic kidney disease and dialysis organization, a community acute care hospital, and an innovation-driven renal care center. The company says it can now more efficiently serve existing customers with facilities in the West and is positioned as an alternative supplier across the continental U.S.

#RMTI Rockwell Medical Adds 30 New Customers in the West

www.stocktitan.net/news/RMTI/rockwell-medic...

Rockwell Medical Extends Product Purchase Agreement Through 2026 With One of the Largest Dialysis Providers in the United States Rockwell Medical (Nasdaq: RMTI) announced that its Amended and Restated Product Purchase Agreement with one of the largest U.S. dialysis providers has been extended through December 31, 2026. The extension includes an increase in product pricing for the extended term. The company said the renewal reflects its reliable supply chain and high-quality hemodialysis products and expressed intent to strengthen and potentially expand the strategic partnership beyond 2026. For additional specifics, Rockwell referenced its Form 8-K filed January 5, 2026.

#RMTI Rockwell Medical Extends Product Purchase Agreement Through 2026 With One of the Largest Dialysis Providers in the United States

www.stocktitan.net/news/RMTI/rockwell-medic...

Rockwell Medical Announces Third Quarter 2025 Results Rockwell Medical (Nasdaq: RMTI) reported third quarter 2025 results on November 12, 2025. Q3 net sales were $15.9M, flat sequentially and down 44% year-over-year after the company's largest customer transitioned to another supplier. The company achieved Adjusted EBITDA of $0.05M in Q3 and reported a net loss of $1.8M for the quarter. Cash, cash equivalents and investments increased to $23.7M at September 30, 2025, up $5.3M from June 30 driven by ATM equity issuances partially offset by the Evoqua asset acquisition.Rockwell reiterated 2025 guidance: net sales $65.0M–$70.0M, gross margin 16%–18%, and Adjusted EBITDA ($0.5M)–$0.5M. Operating actions included restructuring and new long‑term customer agreements, plus a COO promotion.

#RMTI Rockwell Medical Announces Third Quarter 2025 Results

www.stocktitan.net/news/RMTI/rockwell-medic...

Super moment à l’AGM #RMTI! Échanges avec des pros du réseau et partage de notre vision pour renforcer la cybersécurité et la résilience.

#BellCyber #cybersecurite

Great time at #RMTI AGM! Connected with network pros & shared how Bell Cyber + Ateko drive cybersecurity & resilience.

#BellCyber #cybersecurity

🚀 Exciting times for #RMTI! With strong bullish momentum, it's trading above key SMAs & EMAs. RSI suggests overbought, but MACD supports upward movement. Consider a LONG position at $1.80, targeting $1.90 & $2.00. Stay alert for news! 📈 #FeetrAI #StockMarket

🚀 Exciting times for #RMTI! Positive clinical trial results are fueling upward momentum. With strong technicals and a bullish trend, consider entering at $1.65. Targeting $1.75 & $1.85 with a stop loss at $1.55. Confidence is high—let's ride the wave! 📈 #FeetrAI

🚀 Exciting times for #RMTI! Trading at $1.6595, this stock is riding a bullish wave with strong momentum. 📈 With RSI in the mid-60s and a positive MACD, it's not overbought yet. Targeting $1.75 & $1.85 with a stop loss at $1.60. Ready to ride the trend? #FeetrAI

🚀 Exciting times for #RMTI! Trading at $1.69, Rockwell Medical shows bullish momentum with a 10-day SMA of $1.56 and 8-day EMA of $1.61. 📈 MACD supports upward movement, but watch for volatility. Consider entering at $1.68, targeting $1.75 & $1.80. Stay alert! #Stocks #FeetrAI

Rockwell Medical Tops Q2 EPS View | The Motley Fool

#RMTI #59b6ada6-496a-4d60-ab10-c5f7caa7fcbe #data-news

Origin | Interest | Match

Rockwell Medical Stabilizes After Major Customer Exit: Reports $18.4M Cash Position, 80% Long-term Contracts Healthcare firm generates positive cash flow despite revenue challenges, maintains 16% margins and secures new customer contracts. Company builds stability with $18.4M cash position. See details.

#RMTI Rockwell Medical Announces Second Quarter 2025 Results

www.stocktitan.net/news/RMTI/rockwell-medic...

Rockwell Medical Sets Q2 Earnings Date: Key Hemodialysis Updates Expected August 14 Get insights into Rockwell Medical's Q2 2025 performance and hemodialysis portfolio updates. Join leadership team for detailed financial analysis. View details.

#RMTI Rockwell Medical to Release Second Quarter 2025 Results on Thursday, August 14, 2025

www.stocktitan.net/news/RMTI/rockwell-medic...

Rockwell Medical and Innovative Renal Care Announce Three-Year Partnership Agreement to Ensure Supply Chain Continuity of Quality Hemodialysis Products Rockwell Medical (Nasdaq: RMTI) and Innovative Renal Care (IRC) have entered into a three-year partnership agreement for hemodialysis products supply. The multi-million dollar agreement includes supply of liquid and dry acid and bicarbonate hemodialysis concentrates, along with the DAMX45 dry acid concentrate mix system.The partnership aims to enhance IRC's supply chain continuity and streamline workflows across its U.S. dialysis centers. The agreement includes utilization commitments and an option to extend for an additional year. IRC will benefit from reduced storage requirements while maintaining product quality, utilizing Rockwell's CitraPure® and Dri-Sate® dry acid concentrate powders.

#RMTI Rockwell Medical and Innovative Renal Care Announce Three-Year Partnership Agreement to Ensure Supply Chain Continuity of Quality Hemodialysis Products

www.stocktitan.net/news/RMTI/rockwell-medic...

Rockwell Medical Announces First Quarter 2025 Results Rockwell Medical (NASDAQ: RMTI) reported Q1 2025 financial results, with net sales of $18.9 million, down 17% from $22.7 million in Q1 2024, primarily due to their largest customer transitioning to another supplier. The company maintained gross profit at $3.0 million, with improved gross margin of 16% vs 14% in Q1 2024. Net loss improved 12% to $1.5 million compared to $1.7 million in Q1 2024.Cash position decreased to $17.3 million from $21.6 million at year-end 2024. The company confirmed its 2025 guidance with expected net sales of $65-70 million, gross margin of 16-18%, and adjusted EBITDA between ($0.5M) to $0.5M. Notable developments include adding a single-use bicarbonate cartridge to their product portfolio and being named a Great Place to Work® for the third consecutive year.

#RMTI Rockwell Medical Announces First Quarter 2025 Results

www.stocktitan.net/news/RMTI/rockwell-medic...

Upcoming Earnings: Rockwell Medical Sets Date for Q1 2025 Financial Results CEO Mark Strobeck and CFO Jesse Neri to present Q1 performance for the hemodialysis products leader. Join live webcast and Q&A session. Full details inside.

#RMTI Rockwell Medical to Release First Quarter 2025 Results on Monday, May 12, 2025

www.stocktitan.net/news/RMTI/rockwell-medic...

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with strong volume declines, Thu Mar 20th - #YY #PFC #ICCM #EYEN #APVO #RMTI #YRD #XYF #NRGV #CPUH #ALUR - More: crystalequityresearch.com/SmCpStr/ - #smallcap

Rockwell Medical Hits Profitability Milestone: Record $101.5M Revenue, But Major Customer Exit Looms Rockwell Medical reaches EBITDA profitability with 21% revenue growth to $101.5M, while preparing for key customer transition in 2025. Strong cash position supports strategic pivot.

#RMTI Rockwell Medical Announces Fourth Quarter and Full-Year 2024 Financial and Operational Results

www.stocktitan.net/news/RMTI/rockwell-medic...

Rockwell Medical Unveils Advanced Hemodialysis Portfolio: 4 Innovative Solutions at DTX42 Discover Rockwell Medical's comprehensive dialysis portfolio featuring CitraPure, Dri-Sate, RenalPure, and SteriLyte concentrates, plus cost-saving mixing technology at DTX42.

#RMTI Rockwell Medical to Exhibit at DialysisTechConneXion42 in Booth# 112

www.stocktitan.net/news/RMTI/rockwell-medic...

Rockwell Medical Q4 Earnings Preview: Top Executives to Address Hemodialysis Market Strategy Full executive team to present Q4 and 2024 results, followed by analyst Q&A. Join 8:00am ET for strategic insights on hemodialysis business.

#RMTI Rockwell Medical to Release Fourth Quarter and Full-Year 2024 Results on Thursday, March 20, 2025

www.stocktitan.net/news/RMTI/rockwell-medic...

Major Hemodialysis Market Expansion: Rockwell Medical Targets Lucrative $100M Opportunity with FDA-Cleared Product Rockwell Medical secures distribution rights for FDA-cleared bicarbonate cartridges, positioning to capture share in $100M hemodialysis market. Launch set for early 2025.

#RMTI Rockwell Medical Adds Single-Use Bicarbonate Cartridge to Hemodialysis Concentrates Product Portfolio

www.stocktitan.net/news/RMTI/rockwell-medic...

Just In: ( NASDAQ: #RMTI ) Rockwell Medical Enters into a Multi-Year Product Purchase Agreement with the World's Leading Provider of Dialysis Products and Services

#StockMarket #News

Rockwell Medical Signs Major Dialysis Supply Deal: $10M+ Revenue Boost Expected in 2025 Leading U.S. bicarbonate supplier Rockwell Medical secures multi-year partnership with global dialysis leader, projecting significant revenue growth through exclusive supply agreement.

#RMTI Rockwell Medical Enters into a Multi-Year Product Purchase Agreement with the World's Leading Provider of Dialysis Products and Services

www.stocktitan.net/news/RMTI/rockwell-medic...

Rockwell Medical Names Industry Veteran Jesse Neri as New CFO, Bringing 25 Years of Strategic Finance Leadership Rockwell Medical strengthens executive team with Jesse Neri as CFO, leveraging his extensive experience in healthcare finance, product acquisitions, and commercial launches.

#RMTI Rockwell Medical Promotes Jesse Neri to Chief Financial Officer

#stocks #news #investing

www.stocktitan.net/news/RMTI/rockwell-medic...

Rockwell Medical Partners with HydroCare to Revolutionize Dialysis Water Treatment Distribution | RMTI Stock News Rockwell Medical expands reach through strategic partnership with HydroCare, introducing rapid-mixing DAMX45 system for dialysis centers. Learn about this game-changing collaboration.

#RMTI Rockwell Medical Partners with HydroCare to Distribute and Install its Dry Acid Concentrate Mix System

#StockMarket #news #investing

www.stocktitan.net/news/RMTI/rockwell-medic...

#RMTI Rockwell Medical Expands Distribution in the Philippines

www.stocktitan.net/news/RMTI/rockwell-medic...

JUST IN: ( NASDAQ: #RMTI ) Rockwell Medical Announces Date Change for Third Quarter 2024 Earnings Conference Call and Webcast

#StockMarket #News